Protocol register
43 protocols: reconstitution, titration, schedule, and storage. The 20 NovaEvum catalog compounds come first and carry a vial worksheet. Blends are listed as a single vial; you cannot split the ratio.
| Compound | Category | Typical amount | Route | Research score |
|---|---|---|---|---|
| BPC-157NovaEvum | Healing & recovery | 250 mcg | Subcutaneous | 60/100 |
| TB-500NovaEvum | Healing & recovery | 2.0–2.5 mg | Subcutaneous | 60/100 |
| Wolverine StackNovaEvumblend | Healing & recovery | 250 mcg each | Subcutaneous | 60/100 |
| KPVNovaEvum | Healing & recovery | 200–250 mcg | Subcutaneous | 60/100 |
| Thymosin Alpha-1NovaEvum | Healing & recovery | 1.5–1.6 mg | Subcutaneous | 90/100 |
| TesamorelinNovaEvum | Growth hormone | 1 mg | Subcutaneous, abdomen | 90/100 |
| IpamorelinNovaEvum | Growth hormone | 200 mcg | Subcutaneous | 45/100 |
| CJC-1295 / Ipamorelin BlendNovaEvumblend | Growth hormone | 100 mcg each | Subcutaneous | 40/100 |
| Kisspeptin-10NovaEvum | Growth hormone | 100 mcg | Subcutaneous | 75/100 |
| GHK-CuNovaEvum | Skin, hair & aesthetics | 1.0–2.0 mg | Subcutaneous or topical after reconstitution | 85/100 |
| KLOWNovaEvumblend | Skin, hair & aesthetics | 2 mg total | Subcutaneous | 60/100 |
| PT-141NovaEvum | Skin, hair & aesthetics | 0.5–1.0 mg | Subcutaneous | 90/100 |
| RetatrutideNovaEvum | GLP-1 & metabolic | 2 mg | Subcutaneous, once weekly | 90/100 |
| TirzepatideNovaEvum | GLP-1 & metabolic | 2.5 mg | Subcutaneous, once weekly | 95/100 |
| NAD+NovaEvum | Longevity & cellular | 50 mg | Subcutaneous (slow) or as specified by the protocol under study | 85/100 |
| MOTS-cNovaEvum | Longevity & cellular | 5 mg | Subcutaneous | 60/100 |
| GlutathioneNovaEvum | Longevity & cellular | 200 mg | Subcutaneous or as specified by the protocol under study | 85/100 |
| SemaxNovaEvum | Brain & cognitive | 200–300 mcg | Intranasal | 75/100 |
| SelankNovaEvum | Brain & cognitive | 250–500 mcg | Intranasal | 70/100 |
| DSIPNovaEvum | Brain & cognitive | 100 mcg | Subcutaneous | 60/100 |
| Semaglutide | GLP-1 & metabolic | 0.25 → 2.4 mg weekly, titrated | Subcutaneous | 100/100 |
| Mazdutide | GLP-1 & metabolic | 1.5 → 6 mg weekly, titrated | Subcutaneous | 85/100 |
| Survodutide | GLP-1 & metabolic | 0.3 → 4.8 mg weekly, titrated | Subcutaneous | 85/100 |
| Cagrilintide | GLP-1 & metabolic | 0.25 → 2.4 mg weekly, titrated | Subcutaneous | 85/100 |
| GLOW | Skin, hair & aesthetics | 1–2.5 mg GHK-Cu daily (blend) | Subcutaneous | — |
| Sermorelin | Growth hormone | 0.2–0.3 mg nightly | Subcutaneous | 78/100 |
| CJC-1295 (No DAC) | Growth hormone | 0.1–0.2 mg, 1–2× daily | Subcutaneous | 40/100 |
| CJC-1295 (With DAC) | Growth hormone | 1–2 mg weekly | Subcutaneous | 40/100 |
| GHRP-2 | Growth hormone | 0.1–0.3 mg, 1–3× daily | Subcutaneous | 75/100 |
| GHRP-6 | Growth hormone | 0.1–0.3 mg, 1–3× daily | Subcutaneous | 80/100 |
| Melanotan-2 | Skin, hair & aesthetics | 0.25–0.5 mg load, then 2–3× weekly | Subcutaneous | 55/100 |
| Melanotan-1 | Skin, hair & aesthetics | 0.25 mg twice weekly, then weekly | Subcutaneous | 85/100 |
| AOD-9604 | GLP-1 & metabolic | 0.3 mg daily, fasted | Subcutaneous | 60/100 |
| 5-Amino-1MQ | GLP-1 & metabolic | 2.5–5 mg daily | Subcutaneous | — |
| SLU-PP-332 | GLP-1 & metabolic | 0.5–1 mg daily | Subcutaneous | 45/100 |
| SS-31 | Longevity & cellular | 5–10 mg, 2–3× weekly | Subcutaneous | 80/100 |
| IGF-1 DES | Growth hormone | 50–150 mcg around training | Subcutaneous or intramuscular | 55/100 |
| IGF-1 LR3 | Growth hormone | 20–40 mcg daily | Subcutaneous or intramuscular | 40/100 |
| LL-37 | Healing & recovery | 0.1–0.5 mg every other day | Subcutaneous | 75/100 |
| Semax + Selank Blendblend | Brain & cognitive | 0.2–0.5 mg of each daily (blend) | Subcutaneous | — |
| Pinealon | Brain & cognitive | 1–1.5 mg daily, 10–20 day course | Subcutaneous | 70/100 |
| Epitalon | Longevity & cellular | 5–10 mg daily, 10–20 day course | Subcutaneous | 65/100 |
| L-Carnitine | GLP-1 & metabolic | 200–600 mg pre-workout | Subcutaneous or intramuscular | — |